<DOC>
	<DOCNO>NCT01059214</DOCNO>
	<brief_summary>Background : - INFUSE AMI ongoing clinical trial examine patient heart attack treat . The study 's aim help determine best way treat patient specific kind heart attack cause blood clot . - To evaluate effect heart attack heart tissue function , participant INFUSE-AMI study magnetic resonance imaging ( MRI ) scan heart specific time heart attack . Objectives : - To perform cardiac MRI scan patient participate INFUSE-AMI study . Eligibility : - Individuals least 18 year age enrol INFUSE-AMI study . Design : - Participants MRI scan heart 5 day 23 44 day heart attack . The MRI scan day 5 optional . - Participants provide blood sample prior MRI scan . - During scan , participant give contrast drug show blood flow within heart . An electrocardiogram use monitor heart procedure . - No treatment provide protocol .</brief_summary>
	<brief_title>Cardiac MRI Patients Enrolled INFUSE-AMI</brief_title>
	<detailed_description>The purpose research protocol perform contrast enhance cardiac MRI study patient enrol INFUSE-AMI study ( INFUSE-AMI multicenter , open-label control single-blind randomized study 452 patient enrol approximately 50 US European site ) . Patients present anterior ST elevation myocardial infarction electrocardiogram ( STEMI ) occlude proximal mid leave anterior descend artery ( LAD ) TIMI 0/1 flow eligible randomization one follow arm : 1 ) Local infusion Abciximab thrombus aspiration , 2 ) Local infusion Abciximab thrombus aspiration , 3 ) No local infusion thrombus aspiration , 4 ) No local infusion thrombus aspiration . Cardiac MRI perform assess leave ventricular function infarct size primary INFUSE-AMI study . Thus , local research protocol provide cardiac MRI scan cost participant . Additional image heart obtain local research purpose . Cardiac MRI scan perform around 5 day ( optional ) 30 day myocardial infarction .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>INCLUSION CRITERIA : . Signed consent INFUSEAMI ii . Ability travel NIH participation MRI study . iii . Ability provide inform consent , hold valid surrogate decision maker authorization ( Durable Power Attorney ) . EXCLUSION CRITERIA : . Known hypersensitivity contraindication gadolinium contrast ii . Severe kidney disease ( eGFR &lt; 30 mLIminIl .73 ( 2 ) BSA ) iii . Pregnancy iv . Breast feeding ( unless subject willing discard breast milk 24 hour ) v. Cardiac pacemaker implantable defibrillator vi . NonMRI compatible aneurysm clip vii . Neural stimulator ( e.g . TENS unit ) viii . Any implant magnetically activate device ( e.g . insulin pump ) ix . Any type nonMRI compatible metallic ear implant x . Metal shaving orbit xi . Any metallic foreign body , shrapnel , bullet location physician feel would present risk subject</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 11, 2012</verification_date>
	<keyword>Acute Myocardial Infarction</keyword>
	<keyword>Reperfusion</keyword>
	<keyword>MRI</keyword>
	<keyword>Heart Attack</keyword>
</DOC>